
10,000 NZers may have lost vision due to toxoplasmosis
Toxoplasmosis is an infection triggered by a parasite spread by cats. Photo: RNZ
Ten thousand New Zealanders may have lost vision - sometimes permanently - due to toxoplasmosis, an infection triggered by a parasite spread by cats.
Otago University researchers estimate 40,000 people are affected by ocular toxoplasmosis - one in four seriously - but their efforts to develop new treatments are being hampered by a lack of funding.
Danielle Wilson was at work when her vision went blurry.
"I just had like a sudden onset of really sore, red eye and my vision changed, and I couldn't stand bright lights."
Luckily, she works as a nurse in the eye department at Otago University.
"I made myself an appointment to see an optometrist after work, but my colleagues being observant eye staff, all noticed my red eye so they scooped me up and took me and checked my eyes out."
Wilson, who is in her early 30s, was shocked to learn she had toxoplasmosis in her eye.
Doctors told her the parasite - commonly spread by cats - could have lain dormant in her body for years.
Treatment was intense - for the first week, she needed to take eyedrops every hour, and she was on antibiotics and courses of steroids for 18 months.
A couple of years on, she is "always nervous" it could flare up again, and is vigilant for any changes in her eye.
"Unfortunately the scar on my eye is really close to my central vision, so if the scar gets worse, I could lose that vision permanently."
NZ has high rates of infection
Toxoplasma is the leading cause of infectious eye diseases globally and a major contributor to vision loss in New Zealand.
Dr Francesc March de Ribot, Ophthalmology Consultant, Otago University Photo: Supplied
Otago University ophthalmologist Dr Francesc March de Ribot regularly sees patients with toxoplasmosis, including very young people.
One of them, a medical student, has lost central vision in one eye, which has killed his dream of becoming a surgeon.
"When there is inflammation in the retina, the vision becomes blurry, and sometimes we can see when the inflammation goes away, it leaves a scar, and the vision is never going to recover."
World-wide, up to one in three people are infected - but rates could be even higher in New Zealand: 43 percent according to one study in Waikato.
The parasite, Toxoplasma gondii, reproduces in cat guts and is spread through eggs in their faeces.
Cat poo in soil and freshwater can infect birds and mammals, including humans, with toxoplasmosis for up to two years, while the eggs survive in sea water for six months.
For unborn babies and those with weakened immune systems, toxoplasmosis can cause blindness, brain damage and even death - but for most people, it is no worse than a cold.
However, the parasite can live dormant within cysts inside the body, and make people sick when it "reactivates".
De Ribot said it was estimated to seriously affect the sight of about 10,000 New Zealanders, with 1000 recurrences a year.
"It's likely that maybe we have more incidences than other countries, and as well that some people have more difficulty in accessing eye care, so they are not detected or treated on time. So it's definitely a problem."
Research stymied by lack of funding
Otago University professor of parasitology Bruce Russell said current available treatments were not very effective.
"They don't work well against the dormant stage of the parasite. When people are found to have it, they need repeated and long-term treatments, and the current treatment doesn't stop the inflammation, which is the thing that actually destroys part of the eye. It causes retinal destruction."
The good news is Professor Russell has identified some promising compounds for new treatments - but he cannot get funding to develop them in New Zealand.
HIs latest application for a research grant - made with Dr March de Ribot and other top researchers - has just been rejected by the Marsden Fund.
They were asking for $900,000 over three years.
"We had a library of such drugs, that had already been part of a $420 million Novartis [Swiss-based multinational pharmaceutical company] target discovery programme that I was involved in, in Singapore. I try to sell this to people here, but I don't know, it doesn't seem to get through."
The Otago lab, which was testing drugs against both toxo and cryptosporidium, closed in 2023, due to lack of funding.
Most of Professor Russell's work has been farmed out overseas, with Singapore picking up the drug discovery work.
He said the developed world had largely forgotten about parasites.
"But there are a lot of hidden ones, like toxo, which we don't understand. And unfortunately I don't think we really want to try to understand, because if we knew their full impact, it would cause a lot of upset.
"For instance, we think there are probably some big impacts on mental health."
It could also explain why New Zealanders love cats and have one of the highest cat ownership rates in the world (40 percent of households), he (half) joked.
"The parasite rewires the brain of the mouse to go and find cats, so the cat can eat it, and complete the life cycle of the parasite."
Although toxoplasmosis is not a notifiable disease in New Zealand, 142 cases were reported between 2007-2016, including 15 cases of congenital toxoplasmosis (in babies infected in the womb).
It was not just a problem for people, Russell said.
"Toxoplasmosis is a killer of some of our precious native wildlife, including birds like kiwi and kākā, and our unique Hector's and Māui dolphins. It also causes big problems for sheep farmers, leading to the loss of lambs."
Doctors advise people who are pregnant or have a weakened immune system should not eat raw, undercooked or cured meats or products made from unpasteurised milk, wear gloves when emptying cat litter trays, cover children's sandpits, wear gloves to garden and wash their hands before preparing food and eating.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Spinoff
a day ago
- The Spinoff
The Spinoff Essay: A bit of pain
'I'm lucky; I've had it for only five years or so.' David Hill on living with chronic pain. The Spinoff Essay showcases the best essayists in Aotearoa, on topics big and small. Made possible by the generous support of our members. I ache. I'm sore, nearly all the time. I'm one of the estimated 900,000 New Zealanders who suffer from chronic pain. Chronic or neuropathic pain is usually defined as pain that's lasted for more than three months. I'm lucky; I've had it for only five years or so. Multiple thousands of Kiwis have suffered for decades, or their entire life. More statistics. Over 40% of people in the UK are thought to suffer, at various times and to various degrees. (The US estimates almost 50%.) For over-75s in Britain, the figure lifts to 65%. About 80% of this is back and neck pain. In Aotearoa, a 2018 report from research group Sapere suggested that chronic pain costs our health system some $2 billion annually, plus another $15 billion in lost production and benefit costs. Utterly predictably (think housing, working conditions, $60 for a GP visit, $75 for a physio session), it affects lower socio-economic groups more. Oh, and (think trad Kiwi male stereotypes this time), women are more likely to report it than men. In my case, it's cervical spondylosis with foraminal narrowing and radiculopathy. I like to roll out the phrase so I can watch listeners' eyes cross as they wonder how much time I've got left. English translation: my neck is stuffed. Age, plus bad posture at the keyboard, means the cushioning discs between cervical vertebrae have worn thin. Bone spurs have formed. My mobility is limited; I get deep pain in the neck and between shoulder blades, plus intermittent giddiness. I've gone into detail because, like most sufferers – and I dislike that word – I usually don't say much about it. People with chronic pain get little sympathy. Who wants to hear about an ailment that goes on and on, especially when it usually comes with no bandages, slings, plaster, other visible signs of affliction? Like Chronic Fatigue Syndrome and Long Covid, it's easily seen, even by some health professionals, as self-pitying, even malingering. ' Whatever happened to 'pull yourself together'?' I heard one sceptic sniff, after an acquaintance had vented over his months of continuing hip and leg discomfort. It's the least telegenic of ailments; if we do appear on screen, we're usually caricatured as boring old whingers who need to snap out of it. ' It's all in your head,' is another common dismissal. True. Also stupid. Of course it's in the head, because that's where the brain's pain receptors are. We don't register any injury or discomfort till those receptors fire. Trouble is, if the pain continues for more than a few hours, your pre-frontal cortex starts assessing the sensation in terms of what it may mean long-term, and begins reinforcing the synapses associated with stress and discomfort. The brain's 'pain switch' gets stuck in the ON position, and your body becomes convinced of its distress. Neurologist William Davies notes that 'pain carves a path directly between the realms of mind and body'. It's called Control Sensitisation: just as Pavlov's dogs slobbered when a bell rang, almost any tug or tension for a chronic pain sufferer sends those brain receptors into power drive. It means that pain can become a habit, and like many unpleasant habits, it's hard to get rid of. A cycle of discomfort – sleep deprivation – stress – more discomfort and more stress can become established. Withdrawal and depression may follow, with the symbolic Black Dog liable to squat and crap on any of your days. So yes, it is all in the head, and it's utterly genuine. There have been some curious associated discoveries. Women's limbic system responds to pain more than men's, so women often experience greater emotional distress, while the fact that men's pre-frontal cortex is more affected means they may see the issue primarily as a problem to be analysed. And chronic pain may be exacerbated by apparently unassociated events; Brexit, the Covid pandemic, even the Trump presidency saw a rise in reported cases. You're right: the Orange Roughy can indeed become a pain in the arse. Bad news for the next few years. Chronic pain victims make unrewarding patients, even to sympathetic doctors – and not all are. Symptoms are frequently vague and diverse. We're the unwell who can sometimes seem well. Our GPs ask questions, refer us to specialists who ask more questions, at $2 per syllable, rule out nastier possibilities if you're lucky (and that is indeed a help), and usually intone variations on the theme of 'y ou'll have to live with it'. I sympathise with them, actually: as with Chronic Fatigue or Long Covid, we seldom give them the satisfaction of finding a specific cause. So chronic pain is a formless and often unresponsive condition. It can take a long time to get a diagnosis, and it seldom comes with any clear path of action. It can be treated, but seldom cured – whatever that last word may mean. What are the treatments? Painkillers, anti-inflammatories of course, though all of them, except perhaps paracetamol, come with potential side effects. A TROUP (Trends and Risks of Opioid Use for Pain) study in the US found that 22-26% of people prescribed opioids for non-malignant chronic pain ended up misusing their drugs. Distraction, meditation, exercise, diet, therapy, physio and chiropractic, the analytical and shared talk of Cognitive Behavioural Therapy are other courses of action – and action is an early step to taking some degree of control. The New Zealand Pain Society (you'll find them online) offers sensible, practical programmes and resources. Complex Chronic Illness Support, also online, can help as well. Our local hospital used to run chronic pain workshops, where physio, dietitian, psychiatrist, counsellor would reassure attendees that they weren't malingerers; it was a genuine ailment, and here was a list of things that might help. They're the only workshops I've ever attended where some participants stood up every 10 minutes and lay down in the aisle for a bit. They were enormously valuable for their collegial quality, finding that you weren't the only sufferer. They've been discontinued – more funding cuts at Whatu Ora, I gather. Alan Gordon in his book The Way Out estimated that in 2021, there were 1.2 billion chronic pain sufferers worldwide. The number is rising: we're living longer and hurting for longer periods. Other contributing factors include people expecting to be pain-lite and becoming more inclined to seek help when we're not, plus our living in an increasingly isolated society, where loneliness aggravates almost any condition. The outlook isn't great. The future, for me at any rate? Keep learning – in the most positive sense of the verb – to live with it. Take unexpected solace from the fact that on good days, the world can seem brighter and more rewarding than it did before my neck started to pack up. And wonder if assault with the nearest deadly weapon might be a pretty reasonable response to anyone who tells me that it's all in my head.


Otago Daily Times
a day ago
- Otago Daily Times
Public-private healthcare opportunities identified
A strategic report focused on the future of public health services in Otago Central Lakes has identified six potential opportunities for public-private collaboration. The Otago Central Lakes strategic health report was sent to Health Minister Simeon Brown in February by the steering group, which was comprised of Southland MP Joseph Mooney, Health New Zealand, the Central Otago and Queenstown Lakes District Councils, rural health providers, iwi, including kaupapa Māori health providers, Act MP Todd Stephenson and Waitaki MP Miles Anderson. Mr Mooney said the group's objective was to "expedite planning and investment in health services and infrastructure in Otago Central Lakes" — Central Otago District Mayor Tamah Alley said 70% of New Zealanders who lived two or more hours from a hospital resided in that region. The report said health service improvements were required to meet the current and future populations' needs. On a peak day, the district's combined population, which included visitors, was 168,000 — expected to nearly double by 2054, it said. "There is a reputational risk to all of Aotearoa New Zealand if adequate healthcare services are unavailable to deal with international visitor illness or injury." The report identified opportunities to increase public health services by partnering with the private sector, but Mr Anderson said the project was "not asking for public funds". The "early stage" public-private partnerships included in the report, which were "ready for collaboration", are: • The Southern Lakes Public Hospital — the location of which is to be determined — which is a proposed privately financed facility with full public hospital services and future capacity to become a regional hospital. • Lakeview Te Taumata Clinic (Queenstown), a private surgical hospital expected to open in 2027, with opportunities for maternity care and workforce development. • Integrated Care Hub (Wānaka), a planned day surgery with potential space for publicly funded after-hours services. • Wānaka Health Precinct, a private surgical hospital designed with capacity to integrate public services. • Aged-care facilities (Clyde), which are under construction, have the potential to expand into a full suite of publicly funded services for older people in Central Otago. • Securing land and investors in Central Otago for future public health infrastructure, based on the outcomes of the other projects. Additionally, the trust was exploring "innovative mobile modular units" which could be used as consultation rooms, clinics or staff accommodation and wanted to find land to host them in areas where they were needed, the report said. The $2 million funding was required to "complete the groundwork" for community consultation, clinical design and planning process, and technical assessments and detailed business cases Health New Zealand could work with — it already had $400,000 seed funding, it said. Subject to Mr Brown's support, a working group would be established to work with Health New Zealand to progress the proposed solutions — community engagement and consultation would follow.


Scoop
2 days ago
- Scoop
‘HIV Should Not Be A Death Sentence In Fiji' – Call For Testing Amid Outbreak
Article – RNZ There were 490 new HIV cases in Fiji from October – December last year. Fiji's Minister for Health & Medical Services has revealed the latest HIV numbers in the country to a development partner roundtable on the country's response. There were 490 new HIV cases from October – December last year, bringing the 2024 total to 1583. 'Included in this number are 32 newborns diagnosed with HIV acquired through mother-to-child transmission,' Dr Atonio Rabici Lalabalavu said. Fiji declared an outbreak of the disease in January. The Fiji Sun reported around 115 HIV-related deaths in the January-September 2024 period. Fiji's Central Division reported 1100 new cases in 2024, with 427 in the Western Division and 50 in the Northern Division. Of the newly recorded cases, less than half – 770 – have been successfully linked to care, of which 711 have been commenced on antiretroviral therapy (ART). Just over half were aged in their twenties, and 70 percent of cases were male. Dr Lalabalavu said the increase in HIV cases is also seeing an increase in tuberculosis and HIV co-infection, with 160 individuals in a year. He said the ministry strongly encourages individuals to get tested, know their status, and if it is positive, seek treatment. And if it is negative, to maintain that negative status. 'I will reiterate what I have said before to all Fijians – HIV should not be a death sentence in Fiji.' In the Western Pacific, the estimated number of people living with HIV (PLHIV) reached 1.9 million in 2020, up from 1.4 million in 2010. At the time, the World Health Organisation said over the previous two decades, HIV prevalence in the Western Pacific had remained low at 0.1 percent. However, the low prevalence in the general population masked high levels of HIV infection among key populations.